Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1876 1
1881 1
1885 1
1887 2
1888 1
1890 4
1891 2
1892 1
1893 5
1894 1
1895 3
1896 3
1897 1
1898 3
1899 2
1900 2
1905 1
1945 11
1948 43
1949 5
1950 9
1951 10
1952 8
1953 14
1954 8
1955 9
1956 14
1957 13
1958 16
1959 75
1960 4
1961 4
1962 4
1963 14
1964 26
1965 48
1966 41
1967 23
1968 25
1969 55
1970 49
1971 49
1972 50
1973 43
1974 62
1975 80
1976 74
1977 97
1978 107
1979 96
1980 107
1981 107
1982 101
1983 112
1984 138
1985 134
1986 141
1987 139
1988 168
1989 198
1990 172
1991 220
1992 218
1993 193
1994 184
1995 191
1996 210
1997 219
1998 252
1999 266
2000 243
2001 308
2002 346
2003 327
2004 319
2005 336
2006 355
2007 414
2008 426
2009 426
2010 511
2011 560
2012 643
2013 704
2014 767
2015 816
2016 791
2017 752
2018 808
2019 904
2020 1056
2021 1218
2022 1395
2023 1252
2024 464

Text availability

Article attribute

Article type

Publication date

Search Results

19,112 results

Results by year

Filters applied: . Clear all
Page 1
Safety and tolerability of KAN-101, a liver-targeted immune tolerance therapy, in patients with coeliac disease (ACeD): a phase 1 trial.
Murray JA, Wassaf D, Dunn K, Arora S, Winkle P, Stacey H, Cooper S, Goldstein KE, Manchanda R, Kontos S, Grebe KM. Murray JA, et al. Lancet Gastroenterol Hepatol. 2023 Aug;8(8):735-747. doi: 10.1016/S2468-1253(23)00107-3. Epub 2023 Jun 14. Lancet Gastroenterol Hepatol. 2023. PMID: 37329900 Clinical Trial.
Patients in part B received three administrations of KAN-101 or placebo followed by a 3-day oral gluten challenge (9 g per day) 1 week after completing dosing. ...Rapid systemic clearance of KAN-101 was observed and no accumulation on repeated dosing. A future study …
Patients in part B received three administrations of KAN-101 or placebo followed by a 3-day oral gluten challenge (9 g per day) 1 wee …
Sequence analysis and plasmid mobilization of a 6.6-kb kanamycin resistance plasmid, pSNC3-Kan, from a Salmonella enterica serotype Newport isolate.
Chen CY, Nguyen LT, Strobaugh TP Jr. Chen CY, et al. PLoS One. 2022 Jul 14;17(7):e0268502. doi: 10.1371/journal.pone.0268502. eCollection 2022. PLoS One. 2022. PMID: 35834529 Free PMC article.
It possessed highly conserved RNA I/II and Tn602 (IS903-aph-IS903) regions to two other KanR plasmids pSe-Kan and pSBardo-Kan, but carried a mobC-mobA/BD operon. The mobilization proteins encoded by the mob operon of pSNC3-Kan showed high sequence identity (~ …
It possessed highly conserved RNA I/II and Tn602 (IS903-aph-IS903) regions to two other KanR plasmids pSe-Kan and pSBardo-Kan, …
Myocardial fibrosis.
Espeland T, Lunde IG, H Amundsen B, Gullestad L, Aakhus S. Espeland T, et al. Tidsskr Nor Laegeforen. 2018 Oct 12;138(16). doi: 10.4045/tidsskr.17.1027. Print 2018 Oct 16. Tidsskr Nor Laegeforen. 2018. PMID: 30344312 Free article. Review. English, Norwegian.
RESULTATER: Myokardfibrose klassifiseres som interstitiell fibrose og erstatningsfibrose. Fibrose kan forarsake ugunstige endringer i hjertets elektriske og mekaniske funksjon, og forverrer prognosen ved mange hjertesykdommer. Bildediagnostikk og forskning pa biomarkorer h …
RESULTATER: Myokardfibrose klassifiseres som interstitiell fibrose og erstatningsfibrose. Fibrose kan forarsake ugunstige endringer i …
Efficacy of Kan Jang() in Patients with Mild COVID-19: A Randomized, Quadruple-Blind, Placebo-Controlled Trial.
Ratiani L, Pachkoria E, Mamageishvili N, Shengelia R, Hovhannisyan A, Panossian A. Ratiani L, et al. Pharmaceuticals (Basel). 2023 Aug 22;16(9):1196. doi: 10.3390/ph16091196. Pharmaceuticals (Basel). 2023. PMID: 37765004 Free PMC article.
Background and aim. This study aimed to assess the efficacy of the treatment of Kan Jang(), a fixed combination of Andrographis paniculata (Burm. ...The statistical difference in the rates of patients with clinical deterioration in the Kan Jang treatment and placebo …
Background and aim. This study aimed to assess the efficacy of the treatment of Kan Jang(), a fixed combination of Andrographis panic …
Kan Extensions are Partial Colimits.
Perrone P, Tholen W. Perrone P, et al. Appl Categ Struct. 2022;30(4):685-753. doi: 10.1007/s10485-021-09671-9. Epub 2022 Jan 31. Appl Categ Struct. 2022. PMID: 35875343 Free PMC article.
One way of interpreting a left Kan extension is as taking a kind of "partial colimit", whereby one replaces parts of a diagram by their colimits. ...The main result of this paper spells out how a pointwise left Kan extension of a diagram corresponds precisely to a p …
One way of interpreting a left Kan extension is as taking a kind of "partial colimit", whereby one replaces parts of a diagram by the …
Induction.
Kan J. Kan J. Anesth Analg. 2022 Apr 1;134(4):893-894. doi: 10.1213/ANE.0000000000005698. Anesth Analg. 2022. PMID: 35299216 No abstract available.
Early intervention with Kan Jang to treat upper-respiratory tract infections: A randomized, quadruple-blind study.
Narimanyan M, Jamalyan K, Balyan A, Barth A, Palm S, Wikman G, Panossian A. Narimanyan M, et al. J Tradit Complement Med. 2021 Jun 11;11(6):552-562. doi: 10.1016/j.jtcme.2021.06.001. eCollection 2021 Nov. J Tradit Complement Med. 2021. PMID: 34765519 Free PMC article.
Kan Jang significantly alleviated all URTI symptoms starting from the second day of treatment. ...Treatment with Kan Jang was tolerated well. CONCLUSION: This study demonstrates that early intervention with Kan Jang capsules reduces the recovery duration of p …
Kan Jang significantly alleviated all URTI symptoms starting from the second day of treatment. ...Treatment with Kan Jang was …
Efficacy of Kan Jang() in Patients with Mild COVID-19: Interim Analysis of a Randomized, Quadruple-Blind, Placebo-Controlled Trial.
Ratiani L, Pachkoria E, Mamageishvili N, Shengelia R, Hovhannisyan A, Panossian A. Ratiani L, et al. Pharmaceuticals (Basel). 2022 Aug 17;15(8):1013. doi: 10.3390/ph15081013. Pharmaceuticals (Basel). 2022. PMID: 36015163 Free PMC article.
Kan Jang(), the fixed combination of Andrographis paniculata (Burm. ...In this study, for the first time we demonstrate that Kan Jang()/Nergecov() is effective in treating mild COVID-19....
Kan Jang(), the fixed combination of Andrographis paniculata (Burm. ...In this study, for the first time we demonstrate that Kan …
[Kan SoMe bruges i forebyggelsen?].
Grønbæk M. Grønbæk M. Ugeskr Laeger. 2022 Feb 7;184(6):V205089. Ugeskr Laeger. 2022. PMID: 35179121 Free article. Danish. No abstract available.
Is there evidence for cross-domain congruency sequence effect? A replication of Kan et al. (2013).
Aczel B, Kovacs M, Bognar M, Palfi B, Hartanto A, Onie S, Tiong LE, Evans TR. Aczel B, et al. R Soc Open Sci. 2021 Mar 3;8(3):191353. doi: 10.1098/rsos.191353. R Soc Open Sci. 2021. PMID: 33959303 Free PMC article.
In this study, we provide a multi-site replication of three previous experiments of Kan et al. (Kan IP, Teubner-Rhodes S, Drummey AB, Nutile L, Krupa L, Novick JM 2013 Cognition 129, 637-651) which test congruency sequence effect between very different domains: from …
In this study, we provide a multi-site replication of three previous experiments of Kan et al. (Kan IP, Teubner-Rhodes S, Drum …
19,112 results
You have reached the last available page of results. Please see the User Guide for more information.